SUMMARY
Six common myths about canine mast cell tumours
Mast cell tumours are the most common skin neoplasms in dogs, and all veterinary surgeons encounter such cases in their daily clinical practice. Given the significant variability in biological behaviour, the spectrum of clinical presentations is wide, including differences in the risk of metastases or local recurrence. For this reason, mast cell tumours can be highly frustrating not only for general practitioners, but also for specialists. This article presents six common myths about canine mast cell tumours.
Key words: mast cell tumour, canine, oncology
PIŚMIENNICTWO
1. Seguin B. i wsp.: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999) J Am Vet Med Assoc 2001, 218, 1120-1123.
2. Donnelly L. i wsp.: Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours. Vet Comp Oncol. 2015 Mar, 13 (1), 70-6.
3. Mullins M.N. i wsp.: Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). J Am Vet Med Assoc 2006, 228, 91-95.
4. Lejeune A. i wsp.: Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Vet Comp Oncol. 2015, 13 (3), 267-280.
5. Warland J. i wsp.: The utility of staging in canine mast cell tumours. Vet Comp Oncol. 2014 Dec, 12 (4), 287-98.
6. Ferrari R. i wsp.: The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Vet Comp Oncol. 2018, 16, 505-510.
